Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Bhaskara, Vasantha Kumar ^a   Mohanam, Indra ^a   Rao, Jasti S ^a   Mohanam, Sanjeeva ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; RETINOIC ACID; SMALL INTERFERING RNA; TUMOR MARKER;

ADRENERGIC SYSTEM; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; HYPOXIA INDUCIBLE GENE; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MARKER GENE; NERVE CELL DIFFERENTIATION; NEURAL CREST; NEUROBLASTOMA; NEUROBLASTOMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL DIFFERENTIATION; DRUG EFFECT; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASTIC STEM CELLS; NEURAL CREST; NEUROBLASTOMA; RNA, SMALL INTERFERING; SYMPATHETIC NERVOUS SYSTEM; TRETINOIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84857186454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030905     Document Type: Article

References (59)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL, (2007) Neuroblastoma. Lancet 369: 2106-2120.
2. Grimmer MR, Weiss WA, (2006) Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 18: 634-638.
3. Brodeur GM, (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
4. Padera TP, Stoll BR, Tooredman JB, Capen D, di TE, et al. (2004) Pathology: cancer cells compress intratumour vessels. Nature 427: 695.
5. Jain RK, (2003) Molecular regulation of vessel maturation. Nat Med 9: 685-693.
6. Harris AL, (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
7. Dewhirst MW, (2007) Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 67: 854-855.
8. Durand RE, Aquino-Parsons C, (2001) Clinical relevance of intermittent tumour blood flow. Acta Oncol 40: 929-936.
9. Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, et al. (2006) Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res 66: 11736-11744.
10. Toffoli S, Michiels C, (2008) Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275: 2991-3002.
11. Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, et al. (2002) Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A 99: 7021-7026.
12. Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S, (2005) Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16: 554-563.
13. Louie E, Nik S, Chen JS, Schmidt M, Song B, et al. (2010) Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 12: R94.
14. Daneau G, Boidot R, Martinive P, Feron O, (2010) Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clin Cancer Res 16: 410-419.
15. Rofstad EK, Gaustad JV, Egeland TA, Mathiesen B, Galappathi K, (2010) Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int J Cancer 127: 1535-1546.
16. Dong Z, Wang J, (2004) Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem 279: 9215-9221.
17. Cairns RA, Kalliomaki T, Hill RP, (2001) Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61: 8903-8908.
18. Moeller BJ, Richardson RA, Dewhirst MW, (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26: 241-248.
19. McPake CR, Tillman DM, Poquette CA, George EO, Houghton JA, et al. (1998) Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status. Oncol Res 10: 235-244.
20. Zamboni WC, Stewart CF, Thompson J, Santana VM, Cheshire PJ, et al. (1998) Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst 90: 505-511.
21. Ezhilarasan R, Jadhav U, Mohanam I, Rao JS, Gujrati M, et al. (2009) The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice. Int J Cancer 124: 306-315.
22. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91.
23. Semenza GL, (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103.
24. Dewhirst MW, Cao Y, Moeller B, (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425-437.
25. Kim Y, Lin Q, Zelterman D, Yun Z, (2009) Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res 69: 9271-9280.
26. Das B, Tsuchida R, Malkin D, Koren G, Baruchel S, et al. (2008) Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26: 1818-1830.
27. Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, et al. (2011) HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells. Cancer Res 71: 4640-4652.
28. Holmquist L, Lofstedt T, Pahlman S, (2006) Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. Adv Exp Med Biol 587: 179-193.
29. Lu H, Li Y, Shu M, Tang J, Huang Y, et al. (2009) Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas. FEBS J 276: 7291-7304.
30. Jogi A, Ora I, Nilsson H, Poellinger L, Axelson H, et al. (2003) Hypoxia-induced dedifferentiation in neuroblastoma cells. Cancer Lett 197: 145-150.
31. Joshi S, Guleria RS, Pan J, Dipette D, Singh US, (2007) Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation. Biochim Biophys Acta 1772: 1093-1102.
32. Zhao F, Wu T, Lau A, Jiang T, Huang Z, et al. (2009) Nrf2 promotes neuronal cell differentiation. Free Radic Biol Med 47: 867-879.
33. Maris JM, (2005) The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17: 7-13.
34. Chaudary N, Hill RP, (2009) Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab Invest 89: 587-596.
35. Li C, Jackson RM, (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241.
36. Hsieh CH, Lee CH, Liang JA, Yu CY, Shyu WC, (2010) Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep 24: 1629-1636.
37. Weinmann M, Jendrossek V, Guner D, Goecke B, Belka C, (2004) Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J 18: 1906-1908.
38. Holmquist L, Jogi A, Pahlman S, (2005) Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int J Cancer 116: 218-225.
39. Aldinucci C, Maiorca SM, De RP, Palmi M, Sticozzi C, et al. (2010) The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period. Neurochem Res 35: 1691-1699.
40. Liu Y, Song X, Wang X, Wei L, Liu X, et al. (2010) Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. J Cell Biochem 111: 554-563.
41. Malec V, Gottschald OR, Li S, Rose F, Seeger W, et al. (2010) HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 48: 1626-1635.
42. Toffoli S, Feron O, Raes M, Michiels C, (2007) Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha. Biochim Biophys Acta 1773: 1558-1571.
43. Semenza GL, (2011) Oxygen sensing, homeostasis, and disease. N Engl J Med 365: 537-547.
44. Majmundar AJ, Wong WJ, Simon MC, (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309.
45. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, et al. (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413-423.
46. Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, et al. (2010) Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene 29: 2938-2949.
47. Tong QS, Zheng LD, Tang ST, Ruan QL, Liu Y, et al. (2008) Expression and clinical significance of stem cell marker CD133 in human neuroblastoma. World J Pediatr 4: 58-62.
48. Cabarcas SM, Mathews LA, Farrar WL, (2011) The cancer stem cell niche-there goes the neighborhood? Int J Cancer 129: 2315-2327.
49. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, et al. (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949-3959.
50. Li Z, Bao S, Wu Q, Wang H, Eyler C, et al. (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513.
51. Ross RA, Spengler BA, (2007) Human neuroblastoma stem cells. Semin Cancer Biol 17: 241-247.
52. Grynfeld A, Pahlman S, Axelson H, (2000) Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1. Int J Cancer 88: 401-410.
53. Chang HH, Lee H, Hu MK, Tsao PN, Juan HF, et al. (2010) Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 16: 4411-4420.
54. Mumm JS, Kopan R, (2000) Notch signaling: from the outside in. Dev Biol 228: 151-165.
55. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, et al. (2005) Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628.
56. Lofstedt T, Jogi A, Sigvardsson M, Gradin K, Poellinger L, et al. (2004) Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 279: 39223-39231.
57. Pietras A, Gisselsson D, Ora I, Noguera R, Beckman S, et al. (2008) High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 214: 482-488.
58. Reynolds CP, Lemons RS, (2001) Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15: 867-910.
59. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173.